Publication:
Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT

Simple item page
dc.contributor.authorsTurkeri, Levent
dc.date.accessioned2022-03-10T11:19:47Z
dc.date.accessioned2026-01-11T13:14:26Z
dc.date.available2022-03-10T11:19:47Z
dc.date.issued2010
dc.identifier.doidoiWOS:000279294100004
dc.identifier.issn1195-9479
dc.identifier.pubmed20566008
dc.identifier.urihttps://hdl.handle.net/11424/219575
dc.identifier.wosWOS:000279294100004
dc.language.isoeng
dc.publisherCANADIAN J UROLOGY
dc.relation.ispartofCANADIAN JOURNAL OF UROLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleProstate cancer: finasteride extends PSA doubling time during intermittent hormone therapy EDITORIAL COMMENT
dc.typeeditorial
dspace.entity.typePublication
oaire.citation.endPage5169
oaire.citation.issue3
oaire.citation.startPage5169
oaire.citation.titleCANADIAN JOURNAL OF UROLOGY
oaire.citation.volume17

Files

Collections

Araştırma Çıktıları